THE ROLE OF HYPOXIA INDUCIBLE FACTOR ALPHA AND ANTI-CYCLIC CITRULLINATED PEPTIDE IN RHEUMATOID ARTHRITIS EGYPTAIN PATIENTS

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Anti-Carbamylated antibodies as a marker of activity and disability in Rheumatoid Arthritis

Anti-carbamylated protein antibodies in rheumatoid arthritis

COVID-19 among Rheumatoid Arthritis Patients on ‎Immunosuppressive Therapy During the First Wave of the COVID-‎‎19 Pandemic: a Prospective Comparative Study ‎

COVID-19 VACCINE IN EGYPTIAN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS, RHEUMATOID ARTHRITIS AND OTHER RHEUMATIC DISEASES

Anti-cyclic citrullinated peptide antibodies in thediagnosis of rheumatoid arthritis:Correlation with some clinical and laboratory data

COVID-19 Vaccines in a Cohort of Egyptian Patients with Auto-Immune Rheumatic Diseases

Clinical Impact of COVID-19 Infection on Rheumatoid Arthritis Patients

Serum C-Reactive Protein to Albumin Ratio in Egyptian Rheumatoid Arthritis Patients and its Relation to Disease Activity, Physical Function and Psychological Status